×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
PPARG Antikörper (Isoform 1)
PPARG
Reaktivität: Human, Maus, Ratte, Hund, Kaninchen, Meerschweinchen, Affe, Hamster, Ente, Nerz
EIA
Wirt: Kaninchen
Polyclonal
unconjugated
Produktdetails anti-PPARG Antikörper
(ausblenden)
Target
Alle PPARG Antikörper anzeigen
PPARG
(Peroxisome Proliferator-Activated Receptor gamma (PPARG))
Bindungsspezifität
Alle Epitope für PPARG Antikörper
AA 255-268, Isoform 1
Reaktivität
Alle Reaktivitäten für PPARG Antikörper
Human, Maus, Ratte, Hund, Kaninchen, Meerschweinchen, Affe, Hamster, Ente, Nerz
Wirt
Alle Wirte für PPARG Antikörper
Kaninchen
Klonalität
Alle Klonalitäten für PPARG Antikörper
Polyklonal
Konjugat
Alle Konjugate für PPARG Antikörper
Dieser PPARG Antikörper ist unkonjugiert
Applikation
Alle Applikationen für PPARG Antikörper
Enzyme Immunoassay (EIA)
Spezifität
This antibody detects human peroxisome proliferator-activated receptor gamma (PPARG).
Aufreinigung
Purified
Immunogen
Synthetic peptide corresponding to amino acids 255 - 268 of human PPAR gamma isoform 1.
Isotyp
IgG
Top Product
Discover our top product PPARG Primärantikörper
Alternativen
(anzeigen)
anti-Peroxisome Proliferator-Activated Receptor gamma (PPARG) (AA 101-200) antibody
PPARG
Reaktivität: Human, Maus, Ratte, Rind (Kuh), Schaf
WB, ELISA, FACS, IF (p), IF (cc), IHC (p), IHC (fro)
Wirt: Kaninchen
Polyclonal
unconjugated
anti-Peroxisome Proliferator-Activated Receptor gamma (PPARG) (pSer273) antibody
PPARG
Reaktivität: Human, Maus, Ratte, Schaf, Meerschweinchen
WB, ELISA, ICC, IF (p), IF (cc), IHC (p), IHC (fro)
Wirt: Kaninchen
Polyclonal
unconjugated
Anwendungsinformationen
(ausblenden)
Applikationshinweise
ELISA: 1: 8000 - 1: 32000. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Konzentration
1.0mg/mL
Buffer
Phosphate buffered saline pH 7.2 containing 0.01 % Sodium Azide (NaN3)
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Details zu PPARG
(ausblenden)
Target
PPARG
(Peroxisome Proliferator-Activated Receptor gamma (PPARG))
Andere Bezeichnung
PPAR-gamma (PPARG Produkte )
Synonyme
PPAR gamma antikoerper, PPARg2 antikoerper, PPARG antikoerper, Nr1c3 antikoerper, PPAR-gamma antikoerper, PPAR-gamma2 antikoerper, PPARgamma antikoerper, PPARgamma2 antikoerper, NR1C3 antikoerper, CIMT1 antikoerper, GLM1 antikoerper, PPARG1 antikoerper, PPARG2 antikoerper, xPPAR-gamma antikoerper, PPAR-GAMMA antikoerper, PPARGAMMA antikoerper, peroxisome proliferator-activated receptor gamma antikoerper, peroxisome proliferator activated receptor gamma antikoerper, peroxisome proliferator activated receptor gamma L homeolog antikoerper, PPARG antikoerper, Pparg antikoerper, pparg.L antikoerper
Hintergrund
PPARG is a member of the nuclear hormone receptor subfamily of transcription factors. Upon activation, PPARG forms heterodimers with retinoid X receptors (RXRs), and functions to regulate transcription of specific gene sequences. PPARG is principally involved in the cellular assimilation of lipids, with key roles in adipocyte differentiation and adipogenesis. Two alternatively spliced isoforms of PPARG exist, termed PPARG1 and PPARG2, which are identical except for an additional 30 amino acids at the N-terminus of PPARG2. This results in a predominant adipocyte localisation for PPARG2, whilst PPARG1 is ubiquitously expressed. PPARG has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer.Synonyms: NR1C3, PPARG, Peroxisome proliferator-activated receptor gamma
Gen-ID
5468
NCBI Accession
NP_005028
UniProt
P37231
Pathways
MAPK Signalweg , Nuclear Receptor Transcription Pathway , Steroid Hormone Mediated Signaling Pathway , Negative Regulation of Hormone Secretion , Carbohydrate Homeostasis , Regulation of Lipid Metabolism by PPARalpha , Positive Regulation of Endopeptidase Activity , Brown Fat Cell Differentiation , Positive Regulation of fat Cell Differentiation
Zuletzt angesehen
(ausblenden)